Eligibility Hepatitis C, Chronic NCT01057667

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, 18-70 years of age
Description

ID.1

Data type

boolean

hepatitis c, genotype 1 or 4, of over 6 months duration
Description

ID.2

Data type

boolean

treatment-naïve
Description

ID.3

Data type

boolean

negative pregnancy test; female patients of childbearing age and male patients with female partners of childbearing age must use two forms of contraception during treatment and following the last dose of ribavirin in accordance with locally approved label for ribavirin
Description

ID.4

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or breast feeding females or male partners of pregnant females
Description

ID.5

Data type

boolean

previous interferon or ribavirin based therapy or investigational anti-hcv agent
Description

ID.6

Data type

boolean

systemic antiviral therapy with established or perceived activity against hcv </=3 months prior to first dose of study drug
Description

ID.7

Data type

boolean

hepatitis a or b, or hiv infection
Description

ID.8

Data type

boolean

history or evidence of medical condition associated with chronic liver disease other than hcv
Description

ID.9

Data type

boolean

Similar models

Eligibility Hepatitis C, Chronic NCT01057667

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
adult patients, 18-70 years of age
boolean
ID.2
Item
hepatitis c, genotype 1 or 4, of over 6 months duration
boolean
ID.3
Item
treatment-naïve
boolean
ID.4
Item
negative pregnancy test; female patients of childbearing age and male patients with female partners of childbearing age must use two forms of contraception during treatment and following the last dose of ribavirin in accordance with locally approved label for ribavirin
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
pregnant or breast feeding females or male partners of pregnant females
boolean
ID.6
Item
previous interferon or ribavirin based therapy or investigational anti-hcv agent
boolean
ID.7
Item
systemic antiviral therapy with established or perceived activity against hcv </=3 months prior to first dose of study drug
boolean
ID.8
Item
hepatitis a or b, or hiv infection
boolean
ID.9
Item
history or evidence of medical condition associated with chronic liver disease other than hcv
boolean